AI is in the early stages of upending the drug discovery and development process, but there will still need to be a 'lab in the loop'
AI is changing the way drugs are designed and developed. And according to industry experts at the Fortune Brainstorm AI conference, this has the potential to reduce research and development cycles for lifesaving drugs.
San Francisco United States Scott Skellenger Enablement Dmitriy Ryaboy Rory Kelleher Ginkgo Bioworks
Source: fortune.com